C0040690||transforming growth factor β
C0075857||Tauroursodeoxycholic Acid
C0012644||Animal Model
C0021368||Neuroinflammation
C0005390||bile acid
C0075857||tauroursodeoxycholic acid
C0075857||tauroursodeoxycholic acid
C0242912||neuroprotective agent
C0012644||animal models
C0876934||neuropathologies
C0075857||tauroursodeoxycholic acid
C0012644||animal model
C0021368||neuroinflammation
C0075857||tauroursodeoxycholic acid
C1155369||regulation of transforming growth factor β (TGFβ) pathway
C0023810||lipopolysaccharide
C0023810||lipopolysaccharide
C1737200||injected intravenously
C0040690||transforming growth factor β
C0025929||reporter mice
C1571580||Smad-binding element
C1571580||Smad-binding element
C2603343||study
C0006104||brains
C1979963||real-time activation profile
C1155363||TGFβ pathway
C2244559||activation of the TGFβ pathway
C0006104||brain
C0025929||SBE/Tk-Luc mice
C0023810||lipopolysaccharide
C1533685||injection
C1511501||control animals
C0025929||mice
C0023810||lipopolysaccharide
C0075857||tauroursodeoxycholic acid
C0025929||mice
C0023810||lipopolysaccharide
C2244559||TGFβ activation
C0025929||mice
C0023810||lipopolysaccharide
C0075857||tauroursodeoxycholic acid
C0040690||TGFβ3 transcript
C0025929||mouse
C0006104||brain
C0040690||TGFβ3
C0206116||microglia
C0024432||macrophages
C0225336||endothelial cells
C0027882||neurons
C0021469||Inhibition
C0076930||TGFβ receptor
C1137338||SB431542 drug
C0075857||tauroursodeoxycholic acid
C0007613||microglia
C2248379||macrophages activation
C0040690||TGFβ3
C0021368||inflammatory conditions
C0075857||tauroursodeoxycholic acid
C1155363||activation of TGFβ pathway
C0006104||brain
C1171362||expression
C0040690||TGFβ3
C0040690||TGFβ3
C0075857||tauroursodeoxycholic acid
C2244559||activation of the TGFβ pathway
C0040690||transforming growth factor β
C0075857||tauroursodeoxycholic acid
C0021368||neuroinflammatory conditions